CFPB Official Who Challenged Mulvaney's Leadership Stepping Down
(Bloomberg) -- Leandra English is giving up her fight to run the Consumer Financial Protection Bureau.
English, who Democratic lawmakers have claimed for months is the rightful leader of the regulator, plans to step down next week and drop her lawsuit challenging the Trump administration's November decision to name Mick Mulvaney the CFPB's acting director, her lawyer said in a Friday statement.
She decided to resign in light of President Donald Trump's decision to nominate administration budget official Kathy Kraninger as the controversial agency's permanent leader.
English became ensnared in a legal and political firestorm last year when the CFPB's outgoing director Richard Cordray tried to put her in charge as he stepped down to run for governor of Ohio as a Democrat. The Trump administration balked, arguing that it had legal authority to install a temporary director, and the president appointed Office of Management and Budget Director Mulvaney atop the CFPB.
A federal court sided with the Trump administration last year, a ruling that English later appealed. Her lawyer said that she intends to file court papers formally on Monday to bring that litigation to a close.
To contact the reporter on this story: Elizabeth Dexheimer in Washington at edexheimer@bloomberg.net
To contact the editors responsible for this story: Jesse Westbrook at jwestbrook1@bloomberg.net, Alexis Leondis
©2018 Bloomberg L.P.
-
Indians Stay With Family, Not In Hotels | The Reason Why
India still lacks enough clean, reliable and affordable hotels for budget-conscious travellers.
-
The Economic Imperative: Analysing The Material Driving Force Behind India-Canada Strategic Reset
This economic complementarity is further reinforced by deep institutional investment ties and talent mobility, which form the bedrock of the bilateral framework.
-
Medicine Pricing: Where Must Profit Stop?
India must confront excessive margins, hidden incentives and regulatory gaps that threaten the integrity of medicine.
-
Why Amazon And Flipkart Are Struggling To Beat Meesho In India's Smaller Cities
With 274 million users and lowest-cost logistics, Meesho is defending its value commerce crown against giants like Amazon and Flipkart.
-
High US Salaries, No Green Card Certainty: The Financial Calculation Facing Indian H-1B Families
The suspension of PERM processing at eight technology employers does not cancel existing H-1B visas. What it does is force a question many Indian families have been avoiding: is the US salary worth tying your career and family plans to one employer?
-
Swiggy vs Eternal: Food Delivery's Two Rivals Are No Longer In The Same Race
Eternal is building a private AI assistant, dark.ai. Swiggy is still working out how to make Instamart pay, with an operating loss of Rs 895 crore in the July-September quarter while Blinkit stayed profitable.
-
Where You Live Shapes How You Get To Work | The Reason Why
Two-wheelers are the most popular way to get to work in India, accounting for nearly 43% of workplace commutes.
-
Unhedged Position: Can India See An Indonesia-Style Time Correction?
The Nifty is trading below levels it first clocked in 2024. Is there, then, as I have suggested in the headline, potential that the current time correction drags on painfully for the next three-five, even ten years?
-
Navigating Friction And Energy Realities: An Analysis Of Marco Rubio's October Visit To India
Occurring at a critical juncture marked by stalled trade negotiations and escalating geopolitical pressures over global energy supplies, the visit offers a profound window into modern US-India relations.
-
India Exports Capital. Why Not Export Trusteeship?
The big question, then, is whether India can build an institution that global borrowers, investors, banks, and lawyers can trust, even without an Indian connection.
